Ep 25 - John Robson - True Venture Capital vs. Vulture Capital

Today’s guest is John Robson (JR), General Manager at Bridgewest Ventures NZ, and Managing Director of BioOra, a company that is automating the manufacture of CAR T-cells.This episode is brought to you by SAPRO Consulting: https://www.saproconsulting.com.au/The development of new technologies, whether it be medical or otherwise, requires a lot of resources. One of those resources is capital - financial capital. Financial capital for new ventures can come in many forms, including loans from Mom & Pop or the bank, angel investment, grants, or private capital.One of the forms of private capital is venture capital, or VC. VC is characterised by investment in young companies with growth potential. But it's not just about the money. As JR puts it, no founder has every said they were successful because they had an endless supply of money...In this episode, and I discuss:The idiosyncrasies of the New Zealand start-up ecosystemVenture Capital's role to play in the ecosystemBridgwest's portfolio of companies working in the CAR space....and much much more. You can find out more about John Robson and Bridgewest Ventures here: LinkedIn - John Robson (JR)LinkedIn - Bridgewest Ventureshttps://bridgewest.ventures/https://bioora.com/Timestamps:00:00 Teaser00:30 Introduction02:20 True Venture Capital vs. Vulture Capital05:00 Early Stage / Deep Tech Investment09:20 Improving the status quo - Infrastructure, Human Capital, Regulation16:00 Money follows success20:33 Shaping the world around you23:15 Doing more with less25:20 It's not just about the money26:10 Celebrating, and advertising, our successes29:45 Where does the money come from - Bridgewest edition34:30 Industry average is one in ten companies36:20 Early VC - TechTransfer Office involvement40:00 Founder Equity - Bespoke arrangements44:00 Bridgewest's CAR portfolio companies53:15 Advice for Biotech entrepreneursTo get in touch head to: https://www.instagram.com/_good_clinical/Vulture Capital vs. True Venture Capital | John Robson | Ep 25#goodclinical #goodclinicalpodcast #goodclinicalexplains #goodclinicalevents #goodclinicalnetwork #innovation #podcast #newzealand #commercialization #venturecapital #vc #clinicalresearchassociate #technologytransfer #biotech #science #choices #country #entrepreneur #products #clinicalresearch #biotech #clinicalpractice #chatgcp #healthcare #clinicaltrials #medicine #humanhealth